![]() |
USP Non–US MonographsUSP provides standards for articles legally marketed outside the United States if intended to treat neglected diseases. The purpose of these monographs is to support testing by first (e.g., manufacturer), second (e.g., payors), and third (e.g., government control laboratories) parties. Details of the approach are described in the Non–US Guideline. Manufacturers wishing to signal conformance to these monographs may use the following block letters–S–USP. USP Reference Standards to allow testing in accordance with a Non–US monograph may be available in USP's catalogue at a future date. As new and revised Non–US monographs become available, they will be posted on the USP Web site on a monthly basis on the last Friday of each month. Monographs posted in draft for comment will also indicate the deadline for submitting comments and the e–mail address of the USP staff person to whom comments should be directed. Non–US monographs were formerly known as SALMOUS monographs (Standards for Articles Legally marketed Outside the US). For additional information, contact Karen A. Russo, Ph.D., () Draft Monographs — New PostingsPosting Date: October 30, 2009—No new postings Next Posting Date: November 30, 2009 Draft Monographs — Previous Postings
Authorized Monographs — New PostingsPosting Date: October 30, 2009—No new postings Next Posting Date: November 30, 2009 Authorized Monographs — Previous Postings
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||